<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04298346</url>
  </required_header>
  <id_info>
    <org_study_id>RC19_0035</org_study_id>
    <nct_id>NCT04298346</nct_id>
  </id_info>
  <brief_title>Neurological Fate, Prematurity and Genetic Susceptibility Factors</brief_title>
  <acronym>GENIMOC</acronym>
  <official_title>GENIMOC : Neurological Fate, Prematurity and Genetic Susceptibility Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study could help identify aggravating or protective genetic polymorphisms associated
      with cerebral palsy. Populations of premature babies at different risk of cerebral palsy
      could thus be individualized with an impact on their monitoring and on the pathophysiological
      understanding of the processes leading to neurological lesions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify a polymorphism associated with the risk of developing cerebral palsy at 2 years in a regional population of premature infants of gestational age &lt;34 weeks gestation.</measure>
    <time_frame>2 years</time_frame>
    <description>frequency of variants within the case and control groups using the statistical criterion &quot;level of significance&quot; (also called p-value and known by the English word &quot;p-value&quot;) of 5.10-8</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify a specific polymorphism of certain forms of cerebral palsy</measure>
    <time_frame>2 years</time_frame>
    <description>neurological examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Develop a prognosis algorithm for the occurrence of cerebral palsy for personalized monitoring in a population at risk.</measure>
    <time_frame>2 years</time_frame>
    <description>neurological examination</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1305</enrollment>
  <condition>Polymorphism, Restriction Fragment Length</condition>
  <condition>Premature</condition>
  <condition>Infertility of Cervical Origin</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children born prematurely at term &lt;34 weeks between 2008 and 2015, and presenting with
        cerebral palsy at the age of 2 years within the Growing Together Network in Pays de Loire.

        Matching by a propensity score to a population of control children with a comparable
        probability of developing cerebral palsy but whose examination at 2 years is optimal
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children born prematurely at term &lt;34 weeks between 2008 and 2015

          -  assessed at the age of 2 within the Growing Together Network in Pays de Loire

          -  parental consent for the collection of data from their child and for intraoral
             sampling for the search for genetic factors.

        Exclusion Criteria:

          -  children who died after the age of 2

          -  children who refused and / or whose parents refused to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Cyril Flamant, Pr</last_name>
    <phone>0240083483</phone>
    <email>cyril.flamant@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Christophe Roze, Pr</last_name>
    <phone>0240087663</phone>
    <email>jeanchristophe.roze@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Flamant, Pr</last_name>
      <phone>0240083483</phone>
      <email>cyril.flamant@chu-nantes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 2, 2020</study_first_submitted>
  <study_first_submitted_qc>March 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2020</study_first_posted>
  <last_update_submitted>March 4, 2020</last_update_submitted>
  <last_update_submitted_qc>March 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

